Active immunisation for the prevention of influenza caused by influenza virus, types A and B.
Influvac Tetra is indicated in adults and children from 6 months of age.
The use of Influvac Tetra should be based on official recommendations.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education